SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001571049-14-002198
Filing Date
2014-05-30
Accepted
2014-05-30 17:29:16
Documents
1
Group Members
ACMP IV, LLCDANIEL S. JANNEYGUY P. NOHRA

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D (AMENDMENT NO. 1) t79458_sc13da.htm SC 13D/A 137898
  Complete submission text file 0001571049-14-002198.txt   139567
Mailing Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 4153624022
ACP IV, L.P. (Filed by) CIK: 0001282908 (see all company filings)

IRS No.: 200580531
Type: SC 13D/A

Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Subject) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87680 | Film No.: 14881470
SIC: 2836 Biological Products, (No Diagnostic Substances)